Lehrstuhl für Urologie

Krankenhausstraße 12
91054 Erlangen

Untergeordnete Organisationseinheiten

Professur für Molekulare Urologie
Scholz-Stiftungsprofessur für Kinderurologie

Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 6 Go to next page Go to last page

Wach, S., Brandl, M., Borchardt, H., Weigelt, K., Lukat, S., Nolte, E.,... Aigner, A. (2019). Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo. Molecular Therapy - Nucleic Acids, 16, 272-283. https://dx.doi.org/10.1016/j.omtn.2019.02.020
Kahlmeyer, A., Goebell, P., & Wullich, B. (2019). Presurgical assessments. Urologe, 58(4), 373-380. https://dx.doi.org/10.1007/s00120-019-0888-3
Wullich, B., & Wiedemann, A. (2019). Geriatric urology (Geriatrische Urologie). Urologe, 58(4), 369-. https://dx.doi.org/10.1007/s00120-019-0912-7
Kahlmeyer, A., Goebell, P., & Wullich, B. (2019). Presurgical assessments (Assessments vor Operationen). Urologe, 58(4), 373-380. https://dx.doi.org/10.1007/s00120-019-0888-3
Govers, T.M., Hessels, D., Vlaeminck-Guillem, V., Schmitz-Draeger, B.J., Stief, C.G., Martinez-Ballesteros, C.,... Schalken, J.A. (2019). Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study. Prostate Cancer and Prostatic Diseases, 22(1), 101-109. https://dx.doi.org/10.1038/s41391-018-0076-3
Stoehr, C.G., Steffens, S., Polifka, I., Jung, R., Kahlmeyer, A., Ivanyi, P.,... Taubert, H. (2019). Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients. Scientific Reports, 9. https://dx.doi.org/10.1038/s41598-018-38254-3
Erben, P., Sikic, D., Wirtz, R.M., Martini, T., Weis, C.-A., Breyer, J.,... Bolenz, C. (2019). Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder. Virchows Archiv, 474(2), 209–217. https://dx.doi.org/10.1007/s00428-018-2496-9
Cebulla, A., Bolenz, C., Carrion, D.M., & Bellut, L. (2019). Urology training in Germany: international comparison of educational concepts and satisfaction. Urologe, 58(2), 132-138. https://dx.doi.org/10.1007/s00120-019-0854-0
Cebulla, A., Bolenz, C., Carrion, D.M., & Bellut, L. (2019). Urology training in Germany: international comparison of educational concepts and satisfaction Urologische Facharztausbildung im internationalen Vergleich: Wo stehen wir in Deutschland? Urologe, 58(2), 132-138. https://dx.doi.org/10.1007/s00120-019-0854-0
Eckstein, M., Erben, P., Kriegmair, M.C., Worst, T.S., Weiss, C.-A., Wirtz, R.M.,... Erlmeier, F. (2019). Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. European journal of cancer, 106, 234-243. https://dx.doi.org/10.1016/j.ejca.2018.11.007
Polifka, I., Agaimy, A., Herrmann, E., Spath, V., Trojan, L., Stoeckle, M.,... Hartmann, A. (2019). High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma. Human Pathology, 83, 212-223. https://dx.doi.org/10.1016/j.humpath.2018.08.006
Albrecht, A., Penger, T., Marx, M., Hirsch, K., & Dörr, H.-G. (2018). Short-term adverse effects of testosterone used for priming in prepubertal boys before growth hormone stimulation test. Journal of Pediatric Endocrinology & Metabolism, 31(1), 21-24. https://dx.doi.org/10.1515/jpem-2017-0280
Narayan, V., Kahlmeyer, A., Dahm, P., Skoetz, N., Risk, M.C., Bongiorno, C.,... Kunath, F. (2018). Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review. Cochrane Database of Systematic Reviews, 7. https://dx.doi.org/10.1002/14651858.CD012838.pub2
Eckstein, M., Wirtz, R.M., Gross-Weege, M., Breyer, J., Otto, W., Stoehr, R.,... Erben, P. (2018). mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants. International Journal of Molecular Sciences, 19(11). https://dx.doi.org/10.3390/ijms19113396
Eckstein, M., Jung, R., Weigelt, K., Sikic, D., Stoehr, R., Geppert, C.,... Taubert, H. (2018). Piwi-like 1 and-2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients. Scientific Reports, 8. https://dx.doi.org/10.1038/s41598-018-35637-4
Greither, T., Fischer, K., Theil, G., Marcou, M., Holzhausen, H.-J., Weigelt, K.,... Lieb, V. (2018). Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival. Cancer Management and Research , 10, 4173-4180. https://dx.doi.org/10.2147/CMAR.S172069
Kahlmeyer, A., Wullich, B., & Wiedemann, A. (2018). Geriatric Urology. Urologe, 57(4), 387-388. https://dx.doi.org/10.1007/s00120-018-0621-7
Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R., & Schmitz-Draeger, B.J. (2018). Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars series. Urologic Oncology-Seminars and Original Investigations, 36(9), 403-404. https://dx.doi.org/10.1016/j.urolonc.2017.11.006
Eckstein, M., Sikic, D., Strissel, P., & Erlmeier, F. (2018). Evolution of PD-1 and PD-L1 Gene and Protein Expression in Primary Tumors and Corresponding Liver Metastases of Metastatic Bladder Cancer. European Urology, 74(4), 527-529. https://dx.doi.org/10.1016/j.eururo.2018.06.028
Schmidkonz, C., Cordes, M., Beck, M., Goetz, T.I., Schmidt, D., Prante, O.,... Ritt, P. (2018). Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer. Clinical Nuclear Medicine, 43(8), e250-e258. https://dx.doi.org/10.1097/RLU.0000000000002162

Zuletzt aktualisiert 2019-24-04 um 10:30